From the Department of Neurology
Helsinki University Central Hospital
Helsinki, Finland
by
Academic Dissertation
To be publicly discussed with the permission of the Medical Faculty of the University of Helsinki for public examination in Auditorium 4, Helsinki University Central Hospital,Haartmaninkatu 4, on December 15 th , 2000, at 12 noon
Helsinki 2000
SUPERVISED BY:
Docent Markus Färkkilä, M.D., Ph.D.
Helsinki University Central Hospital, Department of Neurology
University of Helsinki
Helsinki, Finland
REVIEWED BY:
Professor Carl G. H. Dahlöf, M.D., Ph.D.
Gothenburg Migraine Clinic
Gothenburg, Sweden
and
Professor Bo Larsson, M.D., Ph.D.
Department of Public Health and Caring Sciences
Section of Caring Science
Uppsala University
Uppsala, Sweden
OPPOSED BY:
Docent Reijo Salonen, M.D., Ph.D.
University of Turku
Turku, Finland
Director, Medical Strategy and Communications
Neurology & Psychiatry Therapeutic Development Group
Group Medical Regulatory and Product Strategy
Glaxo Wellcome
North Carolina, USA
ISBN 952-91-2837-1 (nid.)
ISBN 952-91-2838-X (pdf.)
ISBN 952-91-2839-8 (html)
Yliopistopaino
Helsinki 2000